Other Diseases Related to Thoracic Surgery: Lung Transplantation

Chambers DC, Yusen RD, Cherikh WS, et al; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017 Oct;36(10):1047-1059

Demikhov VP. Transplantation of the heart, lungs and other organs. Eksp Khir Anesteziol 1969;14:3-8.

Metras H. Note preliminaire sur greffe totale du poumon chez le chien. Comp Renal Acad Sci 1950;231:1176-7

Hardy JD, Webb WR, Dalton ML Jr, et al. Lung homotransplantation in man. JAMA 1963;186:1065-74.

Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, Stinson EB, Shumway NE. 1982. Heart– lung transplantation: Successful therapy for patients with pulmonary vascular disease. N Engl J Med 306: 557 – 564.

Toronto Lung Transplant Group: unilateral lung transplantation for pulmonary fbrosis. N Engl J Med 1986;314:1140-5.

Starnes VA, Lewiston NJ, Luikart H, et al. Current trends in lung transplantation: lobar transplantation and expanded use of single lungs. J Thorac Cardiovasc Surg 1992;104:1060-5; discussion 1065-6.

Weill D, Benden C, Corris PA, et al. consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015 Jan;34(1):1-15.)

Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22(11):1183-200.

Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999;160:265–71.

Straznicka M, Follette DM, Eisner MD, et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002;124:250–8.

Pierre AF, Sekine Y, Hutcheon MA, et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002;123:421–8.

Lardinois D, Banysch M, Korom S, et al. Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg. 2005 May;27(5):762-7.

Yeung JC, Keshavjee S. Overview of clinical lung transplantation. Cold Spring Harb Perspect Med 2014;4:a015628

Weder W, Inci I, Korom S, et al. Airway complications after lung transplantation: risk factors, prevention and outcome. Eur J Cardiothorac Surg. 2009; 35: 293-298.

Inci I, Weder W. Airway complications after lung transplantation can be avoided without bronchial artery revascularization. Curr Opin Organ Transplant.

Schuurmans MM, Benden C, Inci I. Practical approach to early postoperative management of lung transplant recipients. Swiss Med Wkly 2013;143:w13773.

Korom S, Boehler A, Weder W. Immunosuppressive therapy in lung transplantation: state of the art. Eur J Cardiothorac Surg. 2009;35(6):1045–55.

Inci-Book Chapter Surgical Complications

Date H, Trulock EP, Arcidi JM, et al. Improved airway healing after lung transplantation. An analysis of 348 bronchial anastomoses. J Thorac Cardiovasc Surg. 1995;110(5):1424-32.

Wildevuur C.R.H., Benfield J.R. A review of 23 human lung transplants by 20 surgeons. Ann Thorac Surg 1970;9:489-515.

Ruttmann E, Ulmer H, Marchese M, et al. Evaluation of factors damaging the bronchial wall in lung transplantation.J Heart Lung Transplant. 2005;24(3):275-81.

Schroder C, Scholl F, Daon E, et al. A modified bronchial anastomosis technique for lung transplantation. Ann Thorac Surg. 2003 ;75(6):1697-704.

Alvarez A, Algar J, Santos F, et al. Airway complications after lung transplantation: a review of 151 anastomoses. Eur J Cardiothorac Surg. 2001;19(4):381-7.

Choong CK, Sweet SC, Zoole JB, et al. Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome. J Thorac Cardiovasc Surg. 2006;131(1):198-203.

Herrera JM, McNeil KD, Higgins RS, et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg. 2001;71:989-93.

Aigner C, Jaksch P, Seebacher G, et al. Single running suture--the new standard technique for bronchial anastomoses in lung transplantation. Eur J Cardiothorac Surg. 2003 ;23(4):488-93.

Murthy SC, Blackstone EH, Gildea TR, et al. Impact of anastomotic airway complications after lung transplantation. Ann Thorac Surg. 2007 Aug;84(2):401-9.

Van De Wauwer C, Van Raemdonck D, Verleden GM, et al. Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg. 2007 ;31(4):703-1.

Takao M., Katayama Y., Onoda K., et al. Significance of bronchial mucosal blood flow for the monitoring of acute rejection in lung transplantation. J Heart Lung Transplant 1991;10:956-967.

Schmid RA, Boehler A, Speich R, et al. Bronchial anastomotic complications following lung transplantation: still a major cause of morbidity? Eur Respir J. 1997;10(12):2872-5.

Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc. 2009 Jan 15;6(1):39-46.

Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction: Part II. Definition. J Heart Lung Transplant 2005;24:1454–1459.

50.Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal NP, Kaiser LR, Kotloff RM. Primary graft failure following lung transplantation. Chest 1998;114:51–60.

King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, Spotnitz WD, Tribble CG, Kron IL. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681–1685.

Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, Landis JR, Kimmel SE. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003;124:1232–1241.

Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081–1091.

Christie JD, Sager JS, Kimmel SE, Ahya VN, Gaughan C, Blumenthal NP, Kotloff RM. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005;127:161–165.

Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT working group on primary lung graft dysfunction: Part V. Predictors and outcomes. J Heart Lung Transplant 2005;24:1483–1488.

Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, DeMissie E, Kimmel SE. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005;171:1312–1316.

Christie JD, Van Raemdonck D, de Perrot M, Barr M, Keshavjee S, Arcasoy S, Orens J. Report of the ISHLT working group on primary lung graft dysfunction: Part I. Introduction and methods. J Heart Lung Transplant 2005;24:1451–1453.

Miotla JM, Jeffery PK, Hellewell PG. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am J Respir Cell Mol Biol 1998;18:197–204.

Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994;58:1158–1162.

Moreno I, Vicente R, Ramos F, Vicente JL, Barbera M. Determination of interleukin-6 in lung transplantation: association with primary graft dysfunction. Transplant Proc 2007;39:2425–2426.

de Perrot M, Bonser RS, Dark J, Kelly RF, McGiffin D, Menza R, Pajaro O, Schueler S, Verleden GM. Report of the ISHLT working group on primary lung graft dysfunction: Part III. Donor-related risk factors and markers. J Heart Lung Transplant 2005;24:1460–1467.

Barr ML, Kawut SM, Whelan TP, Girgis R, Bottcher H, Sonett J, Vigneswaran W, Follette DM, Corris PA. Report of the ISHLT working group on primary lung graft dysfunction: Part IV. Recipient-related risk factors and markers. J Heart Lung Transplant 2005;24:1468–1482.

Cassivi SD, Meyers BF, Battafarano RJ, Guthrie TJ, Trulock EP, Lynch JP, Cooper JD, Patterson GA. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002;74:1663–1669. (discussion 1669–1670).

Szeto WY, Kreisel D, Karakousis GC, Pochettino A, Sterman DH, Kotloff RM, Arcasoy SM, Zisman DA, Blumenthal NP, Gallop RJ, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg 2002;124:241–249.

Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, Keshavjee S. Report of the ISHLT working group on primary lung graft dysfunction: Part VI. Treatment. J Heart Lung Transplant 2005;24:1489–1500.

Adatia I, Lillehei C, Arnold JH, Thompson JE, Palazzo R, Fackler JC, Wessel DL. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57:1311–1318.

Date H, Triantafillou AN, Trulock EP, Pohl MS, Cooper JD, Patterson GA. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913–919.

Macdonald P, Mundy J, Rogers P, Harrison G, Branch J, Glanville A, Keogh A, Spratt P. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 1995;110:861–863.

Fiser SM, Kron IL, McLendon Long S, Kaza AK, Kern JA, Tribble CG. Early intervention after severe oxygenation index elevation improves survival following lung transplantation. J Heart Lung Transplant 2001;20:631–636.

Meyers BF, Sundt TM III, Henry S, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000;120:20–26.

Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM III. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001;122:92–102.

Kermeen FD, McNeil KD, Fraser JF, McCarthy J, Ziegenfuss MD, Mullany D, Dunning J, Hopkins PM. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant 2007;26:850–856.

Amital A, Shitrit D, Raviv Y, et al. The use of surfactant in lung transplantation. Transplantation. 2008 Dec 15;86(11):1554-9.

Inci I, Zhai W, Arni S, Hillinger S, Vogt P, Weder W. N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg 2007;84:240–246.

Chamogeorgakis TP, Kostopanagiotou GG, Kalimeris CA, Kabouroglou GI, Kourtesis AN, Routsi CI, Dima CC, Toumpoulis IK. Effect of n-acetyl-l-cysteine on lung ischaemia reperfusion injury in a porcine experimental model. ANZ J Surg 2008;78:72–77.

Wolf PS, Merry HE, Farivar AS, McCourtie AS, Mulligan MS. Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury. J Thorac Cardiovasc Surg 2008;135:656–665.

Christie JD, Edwards LB, Kucheryavaya AY, et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012 ;31(10):1073-86.

Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg. 2007;31(3):468-73.

Hoopes CW, Kukreja J, Golden J, et al. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg 2013;145:862-68.

Barr ML, Schenkel FA, Cohen RG, et al. Recipient and donor outcomes in living related and unrelated lobar transplantation. Transplant Proc 1998; 30: 2261-2263.

Aigner C, Jaksch P, Taghavi S, et al. Donor total lung capacity predicts recipient total lung capacity after size-reduced lung transplantation. J Heart Lung Transplant 2005; 24: 2098-2102.

Aigner C, Winkler G, Jaksch P, et al. Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage. Transplant Proc 2004; 36: 2801-2805.

Shigemura N, Bermudez C, Hattler BG, et al. Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases. J Heart Lung Transplant 2009; 28: 130-134.

Artemiou O, Wieselthaler G, Zuckermann A, et al. Downsizing of the donor lung: peripheral segmental resections and lobar transplantation. Transplant Proc 1997; 29: 2899-2900.

Aigner C, Mazhar S, Jaksch P, et al. Lobar transplantation, split lung transplantation and peripheral segmental resection--reliable procedures for downsizing donor lungs. Eur J Cardiothorac Surg 2004; 25: 179-183.

Santos F, Lama R, Alvarez A, et al. Pulmonary tailoring and lobar transplantation to overcome size disparities in lung transplantation. Transplant Proc 2005; 37: 1526-1529.

Inci I, Irani S, Kestenholz P, et al. Donor predicted post-operative forced expiratory volume in one second predicts recipients' best forced expiratory volume in one second following size-reduced lung transplantation. Eur J Cardiothorac Surg. 2011:39:115-9.

Benden C, Inci I, Weder W, Boehler A. Size-reduced lung transplantation in children--an option worth to consider! Pediatr Transplant. 2010;14(4):529-33..

Inci I, Schuurmans, Kestenholz P, et al. Long-term outcomes of bilateral lobar lung transplantation. Eur J Cardiothorac Surg. 2012.

Inci I. Donors after cardiocirculatory death and lung transplantation. J Thorac Dis 2017;9(8):2660-2669.

Cypel M, Levvey B, Van Raemdonck D, et al. International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report. J Heart Lung Transplant 2015;34:1278-82.

Cypel M, Sato M, Yildirim E, et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant. 2009;28:753-8.

Levvey BJ, Harkess M, Hopkins P, et al. Excellent Clinical Outcomes from a National Donation-After-Determination-of-Cardiac-Death Lung Transplant Collaborative. Am J Transplant 2012;12: 2406-13.

Snell G.I., B.J. Levvey , T. Oto et al., Early lung transplantation success utilizing controlled donation after cardiac death donors, Am J Transplant 2008;8:1282–1289.

De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant 2009;28:380-7.

Steen S, Söberg T, Pierre L, et al. Transplantation of lungs from a non-hear-beating donor. Lancet 2001;357:825-29.

Krueger T, Berutto C, Aubert JD: Challenges in lung transplantation. Review article. Swiss Med Wkly. 2011;141:w13292.

Wierup P, Haraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg. 2006;81:460-6.

Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012;144:1200-6.

Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;14;364:1431-40.

Aigner C, Slama A, Hötzenecker K, et al. Clinical ex vivo lung perfusion--pushing the limits. Am J Transplant. 2012;12:1839-47.

Inci I, Arni S, Acevedo C, et al. Surfactant alterations following donation after cardiac death donor lungs. Transpl Int. Inci I, Ampollini L, Arni S, et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant. 2008;27(11):1229-36.

Inci I, Arni S, Inci D, et al. Impact of topical cooling solution and prediction of pulmonary graft viability from non-heart-beating donors. J Heart Lung Transplant. 2008 ;27(9):1016-22.

Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant. 2007;26:1054-60.

Inci I, Yamada Y, Hillinger S, et al. Successful lung transplantation after donor lung reconditioning with urokinase in an ex-vivo lung perfusion system. Ann Thorac Surg 2014;98:1837-8.

Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010;16(8):927-33.

Tsuchiya T, Sivarapatna A, Rocco K, Nanashima A, Nagayasu T, Niklason LE. Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration. Organogenesis. 2014 Apr-Jun;10(2):196-207.

Doi R, Tsuchiya T, Mitsutake N, et al. Transplantation of bioengineered rat lungs recellularized with endothelial and adipose-derived stromal cells. Sci Rep. 2017 Aug 16;7(1):8447.

Hofer M, Benden C, Inci I, et al. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant 2009; 28:334-9.

Inci I, Stanimirov O, Benden C, et al. Lung transplantation for cystic fibrosis: a single center experience of 100 consecutive cases. Eur J Cardiothorac Surg. 2012:41:435-40.